Finally! The British government has given the green light for the new nuclear reactor in Somerset. The project could either bolster or wreck EDF, the majority shareholder. Why? I have taken a closer look at the financials of the deal.
No firefighting but fundamental changes ahead for new BMW CFO, WSJ
U.S.-based pharma still banking on new British digs, WSJ
Discourse With ChemChina Could Be Hurdle For New Syngenta CFO, WSJ
Britain’s Prime Minister May Pledges to Tackle Corporate Misbehavior, WSJ
Yuan’s Reserve Currency Status No Game Changer for Companies, WSJ
Deutsche Bank, E.ON Fuel Spike in German Goodwill Impairments, WSJ
Hinkley Deal Could Be Make or Break For EDF, Analysts Say, WSJ
Bayer moving out its comfort zone with Monsanto bid, WSJ
75 % debt financing, a rights issue plus a potential downgrade: In my first story for the Wall Street Journal’s CFO Journal, I take a closer look at why Bayer’s financing for the Monsanto takeover marks a departure from its typical, conservative approach to acquisition funding.
European Corporate Investment May Lag Despite ECB Bond Buying, WSJ
The ECB today decided to keep interest rates and its asset purchasing program unchanged. For the Wall Street Journal’s CFO Journal, I have spoken to companies about what the ECB’s corporate bond buying means for them – and their appetite for M&A, share buy-backs and further expansion.